Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Araceli Biosciences Inc.

0001975014-25-000004 · filed Dec 9, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other Technology filings

Offering

Industry
Other Technology
Exemptions
Rule 506(b)
Reported offering amount
$14,061,994
Reported amount sold
$12,236,994
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Araceli Biosciences Inc.
CIK
1975014
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2022
Address
7405 SW Tech Center Drive, Suite A160
TIGARD, Oregon 97223-8080
Phone
971-713-2676

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗